OncoLink Cancer Treatment and Resources
OncoLink Cancer Treatment and Resources
Link to OncoLink

Lower Extremity Lymphedema

Ultima Vez Modificado: 5 de abril del 2007

Question

Dear OncoLink "Ask The Experts,"

Can you tell me the current data on the incidence of lymphedema in the legs and genitals following surgery, external and internal radiation and chemotherapy for uterine cancer?

Is there good documentation?

Answer

Linda McGrath Boyle PT, DPT CLT-LANA, Cancer Rehab Specialist and OncoLink Lymphedema Team Editor, responds:

In women with stage IB-IIA cervical cancer, the occurrence of lymphedema has been documented from 3-21%. In a recent article by Bergmark et al., published in the International Journal of Gynecological Cancer, 21% of women with stage IB-IIA cervical cancer reported lymphedema symptoms. The women had been treated for cervical cancer with varying treatments, including radical hysterectomy. When compared with population controls (without cancer), they had an 8-fold increase in symptoms indicating lymphedema. Twenty-five percent of these women reported distress due to the lymphedema. Ninety percent of the patients stated they were not willing to trade off survival for freedom from symptoms.

A study in 2003 by Ryan et al. from Australia looked at all types of gynecologic cancers. The diagnosis of lower limb lymphedema was made in 18% of the total sample (490): 53% of these were diagnosed within 3 months of treatment, a further 18% within 6 months, 13% within 12 months, and the remaining 16% up to 5 years following treatment. Women most at risk for developing lymphedema were those who had treatment for vulvar cancer with removal of lymph nodes and follow-up radiotherapy. For this group of women, the prevalence was 47%. In addition, this study determined that many cases occurred within the first year of treatment, which was earlier than previously thought.

Of course, the co morbidities depend upon the stage of the cancer at diagnosis, the surgical approach (i.e. lymphadenectomy), and the radiation dose received. Obesity is also a risk factor for Lymphedema.

This is just a sample of the evidence found in medical literature. You can use PubMed to search for medical literature.

OncoLink I wish u knew...

Dr. Rustgi discusses genomics and cancer and translating laboratory research into clinical practice. Read more.

Cancer Types
Bone Cancer
Brain Tumors
Breast Cancer
Carcinoid Tumors
Endocrine System Cancers
Gastrointestinal Cancers
Gynecologic Cancers
Head and Neck Cancers
Leukemia
Lung Cancers
Lymphomas
Myelomas
Pediatric Cancers
Penile Cancer
Prostate Cancer
Sarcomas
Skin Cancers
Testicular Cancer
Thyroid Cancer
Urinary Tract Cancers
OncoLink Vet

Cancer Treatment
Biologic Therapy
Bone Marrow Transplants
Chemotherapy

Clinical Trials
Complementary Medicine
Gene Therapy
General Treatment Concerns
Hormone Therapy
PDT Center
Proton Therapy
Radiation Oncology
Surgical Oncology
Targeted Therapies
Vaccine Therapies

Cancer Support
Caregivers
Hospice Care and Bereavement
Nutrition and Cancer
Sexuality & Fertility
Side Effects
Support
Survivorship
Exercise and Cancer

Cancer Resources
Cancer News
OncoLink University
Nurses' Notes
Conferences
Newly Diagnosed Patients
Causes and Prevention
Legal and Financial Information for Patients
LGBT Resources
NCI Resources
Global Resources
Cancer Resource List
Resources for Young Adults

OncoLink Media Library
OncoLink TV
Book, Music and Video Reviews


Ask the Experts
Brown Bag Chat
Tracy's Corner

About OncoLink
About OncoLink
Giving to OncoLink
Contact Information
Usage Policy
Editorial Board
How to Partner with OncoLink
Link to OncoLink
Mission Statement

OncoLink Cancer Resources RSS What's New RSS